Dr. Sentana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215
Summary
- Dr. Daniel Sentana is an oncologist specializing in genitourinary oncology, currently based in Boston, MA. He completed his fellowship in Hematology and Medical Oncology at Beth Israel Deaconess Medical Center, where he also finished his residency in Internal Medicine. Dr. Sentana is employed as a physician at Dana-Farber Cancer Institute at the Lank Center for Genitourinary Oncology. His often-cited research includes publications on prostate cancer and quality of life assessments
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2024- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2018 - 2021
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2018
Certifications & Licensure
MA State Medical License 2018 - 2025
Publications & Presentations
PubMed
- 1 citationsPatient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED).Daniel Sentana-Lledo, Xiangying Chu, David F Jarrard, Michael A Carducci, Robert S DiPaola
European Urology Oncology. 2024-04-29 - Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer.Daniel Sentana-Lledo, Alicia K Morgans
Current Oncology Reports. 2024-03-01 - 13 citationsexon 20 insertion mutations andmutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates.Daniel Sentana-Lledo, Emmeline Academia, Hollis Viray, Deepa Rangachari, Susumu S Kobayashi
Translational Lung Cancer Research. 2023-07-31
Press Mentions
Analyzing Quality of Life and Survival from CHAARTED Prostate Cancer Trial - Daniel Sentana LledoJuly 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
